EGFR and colorectal cancer: This clonal evolution hypothesis has been demonstrated after epidermal growth factor receptor (EGFR)-ablative therapy, where a very low number of Kirsten rat sarcoma viral oncogene homolog (KRAS)-mutated colorectal cancer cells emerged to become the dominant clone among the surviving cells [43, 44].